These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Chronic inflammation and AA amyloidosis]. Blank N; Schönland SO Dtsch Med Wochenschr; 2013 Sep; 138(37):1835-8. PubMed ID: 24006165 [TBL] [Abstract][Full Text] [Related]
27. [Hepatic amyloidosis]. Dao T; Davy A; Verwaerde JC; Galateau F; Valla A Gastroenterol Clin Biol; 1990; 14(6-7):534-43. PubMed ID: 2397862 [No Abstract] [Full Text] [Related]
28. [Treatment and prognosis of secondary amyloidosis in the course of rheumatic disease]. Wiland P; Szechiński J Pol Arch Med Wewn; 2003 Jul; 110(1):797-802. PubMed ID: 14682217 [No Abstract] [Full Text] [Related]
34. Amyloidosis: a familiar problem in the light of current pathogenetic developments. Kisilevsky R Lab Invest; 1983 Oct; 49(4):381-90. PubMed ID: 6353059 [No Abstract] [Full Text] [Related]
38. Temperature-induced dissociation of serum amyloid protein SAA. Linke RP Z Immunitatsforsch Immunobiol; 1979 Feb; 155(3):255-61. PubMed ID: 85376 [TBL] [Abstract][Full Text] [Related]
39. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice. van Rijswijk MH; van Heusden CW Am J Pathol; 1979 Oct; 97(1):43-58. PubMed ID: 495695 [TBL] [Abstract][Full Text] [Related]
40. The systemic amyloidoses: an overview. Falk RH; Skinner M Adv Intern Med; 2000; 45():107-37. PubMed ID: 10635047 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]